Methyl 4-bromo-2,5-dimethylbenzoate

Catalog No. :
ACEWUZ364
CAS No. :
1195230-23-9
Molecular Formula :
C10H11BrO2
Molecular Weight :
243.10

IUPAC Name:methyl 4-bromo-2,5-dimethylbenzoate

Methyl 4-bromo-2,5-dimethylbenzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$61.00Login to see priceIn stockIn stock
250mg97%$91.00Login to see priceIn stockIn stock
1g97%$278.00Login to see priceIn stockIn stock
5g97%$1140.00Login to see priceInquiryInquiry
25g97%$4734.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 4-bromo-2,5-dimethylbenzoate
IUPAC Namemethyl 4-bromo-2,5-dimethylbenzoate
MDL No.MFCD18905462
Molecular FormulaC10H11BrO2
Molecular Weight243.10
SMILESO=C(OC)C1=CC(C)=C(Br)C=C1C
InChI KeyZCPFWYVGOCOTQY-UHFFFAOYSA-N
SynonymMethyl 4-bromo-2,5-dimethylbenzoate;Benzoic acid, 4-bromo-2,5-dimethyl-, methyl ester
CAS No.1195230-23-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACEWUZ364 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACUFKG605 route compound structure diagram
    ACUFKG605276677-03-3 In Stock
  4. Then
  5. ACEWUZ364 route product structure diagram
    ACEWUZ3641195230-23-9 In Stock
Inquiry

2. ACEWUZ364 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUFKG605 route compound structure diagram
    ACUFKG605276677-03-3 In Stock
  4. Then
  5. ACEWUZ364 route product structure diagram
    ACEWUZ3641195230-23-9 In Stock
Inquiry

Comments (0)